Methadone, Buprenorphine and the Community Online

This course meets the training requirements (minimum every five years) for pharmacists dispensing methadone.  

Last Chance until Fall 2024! Please note this program will not be offered again until Fall 2024.




This course consists of two webinars presented over two evenings:

July 2024:

  • Part I – July 16, 2024, 6:00 pm to 8:00 pm
  • Part II – July 24, 2024, 6:00 pm to 9:00 pm

Learning Objectives:

Opioid Agonist Therapy (45 minutes) 

  • Identify those at risk for opioid use disorder.   
  • Discuss treatment options for OUD​.   
  • Review safe prescribing and dispensing of opioid agonist therapy.   
  • Outline the components of a comprehensive OAT program. ​   
  • Discuss strategies for interprofessional collaboration and to reduce stigma​.   


Opioid Agonist Therapy: Special Topics (45 minutes) 

  • Identify options for pain control for patients on Opioid Agonist Therapies.  
  • Discuss co-prescribing of benzodiazepines with OAT​. 
  • Review management of pregnant patients with Opioid Use Disorder.   
  • Explore the role of the pharmacist in harm reduction.   


Policies Guiding Methadone Dispensing in Ontario (30 minutes) 

  • Identify CPSO and OCP policies that pharmacists should refer to when dispensing methadone in Ontario. ​   
  • Review current OCP Opioid Policy.  
  • Review labelling, documentation, and staff training requirements for dispensing methadone.   
  • List required and additional references and resources for dispensing methadone. ​   
  • Review buprenorphine/naloxone dispensing.   


Operationalizing Methadone Dispensing Policies in Ontario (1 hour) 

  • Review and describe OCP Opioid Policy for dispensing methadone in Ontario​   
  • Describe how OCP Opioid Policy and best practices can be implemented in your pharmacy practice.   
  • Find practical resources and tools to work and run OAMT dispensing pharmacies.   


Destigmatizing Opioid Use Disorder (30 minutes) 

  • Describe the impact of stigma on patients with opioid use disorder​.   
  • Communicate effectively through the use of non-stigmatizing language when dealing with sensitive or discrete issues.   


Interview with a Person with Lived Experience (30 minutes – this section is unaccredited) 

  • Consider the impact of stigma when dealing with patients who use opioids.    
  • Learn about stigma from a person with lived experience.   
  • Reflect on your role in reducing stigma in your practice. 


This course is supported by funding from the Mental Health and Addiction Centre of Excellence of Ontario Health. 

Course at a Glance:

Who Should Take This Course:

Successful completion of this course qualifies as an approved training course as part of their training update for pharmacists dispensing methadone. Updates are required at minimum every five years as indicated in the Ontario College of Pharmacists’ Opioid Policy. Please note that this course does not replace the CAMH Opioid Use Disorder (OUDT) course, which Designated Managers and pharmacists are required to complete to dispense methadone as outlined in the Ontario College of Pharmacists’ Opioid Policy. This course is open and applicable to all pharmacy professionals including students and pharmacy technicians. Any pharmacy professionals who are interested in or currently dispensing methadone are welcome to attend.

Development Team:

Cancelation Policy:

Please refer to OPA’s Terms and Conditions of Purchase for cancellation policies.